The representation of medical data and knowledge is fundamental in the field of medical informatics. Ontologies and related artifacts are important tools in knowledge representation, yet they are often given little attention and taken for granted. In this chapter, we give an overview of the development of medical ontologies, including available ontology repositories and tools. We highlight some ontologies that are particularly relevant to clinical research, and describe with examples the benefits of using ontologies to facilitate research workflow management, data integration and electronic phenotyping.
Ontology development
Ontology development has not yet been formalized to the same extent as, say, database development has, and there is still no equivalent for ontologies to the entity-relationship model. However, ontology development is guided by fundamental ontological distinctions and supported by the formalisms and tools for knowledge representation that have emerged over the past decades. Several top-level ontologies provide useful constraints for the development of domain ontologies and one of the most recent trends is increased collaboration among the creators of ontologies for coordinated development.
Important ontological distinctions
A small number of ontological distinctions inherited from philosophical ontology provide a useful framework for creating ontologies. The first distinction is between types and instances. Instances correspond to individual entities (e.g., my left kidney, the patient identified by 1234), while types represent the common characteristics of sets of instances (e.g., a kidney is a bean-shaped, intraabdominal organ -properties common to all kidneys) [5] . Instances are related to the corresponding types by the relation instance of. For example, my left kidney is an instance of kidney. (It must be noted that most biomedical ontologies only represent types in reference to which the corresponding instances are recorded in patient records and in laboratory notebooks). Another fundamental distinction is between continuants and occurrents [6] . While continuants exist (endure) through time, occurrents go through time in phases. Roughly speaking, objects (e.g., a liver, an endoscope) are continuants and processes (e.g., the flow of blood through the mitral valve) are continuants. One final distinction is made between independent and dependent continuants. While the kidney and its shape are both continuants, the shape of the kidney "owes" its existence to the kidney (i.e., there cannot be a kidney shape unless there is a kidney in the first place). Therefore, the kidney is an independent continuant (as most objects are), whereas its shape is a dependent continuant (as are qualities, functions and dispositions, all dependent on their bearers). These distinctions are important for ontology developers, because they help organize entities in the ontology and contribute to consistent ontology development, both within and, more importantly for interoperability, across ontologies.
Building blocks: Top-level ontologies and Relation Ontology
These ontological distinctions are so fundamental that they are embodied by toplevel ontologies such as BFO [7] (Basic Formal Ontology) and DOLCE [8] (Descriptive Ontology for Linguistic and Cognitive Engineering). Such upperlevel ontologies are often used as building blocks for the development of domain ontologies. Instead of organizing the main categories of entities of a given domain under some artificial root, these categories can be implemented as specializations of types from the upper-level ontology. For example, a protein is an independent continuant, the catalytic function of enzymes is a dependent continuant, and the activation of an enzyme through phosphorylation is an occurrent. Of note, even when they do not leverage an upper-level ontology, most ontologies implement these fundamental distinctions in some way. For example, the first distinction made among the semantic types in the UMLS Semantic Network [9] is between Entity and Event, roughly equivalent to the distinction between continuants and occurrents in BFO. While BFO and DOLCE are generic upper-level ontologies, Bio-Top -itself informed by BFO and DOLCE -is specific to the biomedical domain and provides types directly relevant to this domain, such as Chain Of Nucleotide Monomers and Organ System. BFO forms the backbone of several ontologies form the Open Biomedical Ontologies (OBO) family and Bio-Top has also been reused by several ontologies. Some also consider the UMLS Semantic Network, created for categorizing concepts from the UMLS Metathesaurus, an upper-level ontology for the biomedical domain [9] .
In addition to the ontological template provided for types by upper-level ontologies, standard relations constitute an important building block for ontology development and help ensure consistency across ontologies. The small set of relations defined collaboratively in the Relation Ontology [5] , including instance of, part of and located in, has been widely reused.
Formalisms and tools for knowledge representation
Many ontologies use description logics for their representation. Description logics (DLs) are a family of knowledge representation languages, with different levels of expressiveness [10] . The main advantage of using DL for ontology development is that DL allows developers to test the logical consistency of their ontology. This is particularly important for large biomedical ontologies. Ontologies including OCRe, OBI, SNOMED CT and the NCI Thesaurus, discussed later in this chapter, all rely on some sort of DL for their development.
Ontologies are key enabling resources for the Semantic Web, the "web of data", where resources annotated in reference to ontologies can be processed and linked automatically [11] . It is therefore not surprising that the main language for representing ontologies, OWL -the Web Ontology Language, has its origins in the Semantic Web. OWL is developed under the auspices of the World Wide Web Consortium (W3C). The current version of the OWL specification is OWL 2, which offers several profiles (sublanguages) corresponding to different levels of expressivity and support of DL languages [12] . Other Semantic Web technologies, such as RDF/S (Resource Description Framework Schema) [13] and SKOS (Simple Knowledge Organization System) [14] have also been used for representing taxonomies and thesauri, respectively.
The OWL syntax can be overwhelming to biologists and clinicians, who simply want to create an explicit specification of the knowledge in their domain. The developers of the Gene Ontology created a simple syntax later adopted for the development of many ontologies from the Open Biomedical Ontologies (OBO) family. The so-called OBO syntax [15, 16] provides an alternative to OWL, to which it can be converted [17] .
The most popular ontology editor is Protégé, developed at the Stanford Center for Biomedical Informatics Research for two decades [18, 19] . Originally created for editing frame-based ontologies, Protégé now supports OWL and other Semantic Web languages. Dozens of user-contributed plugins extend the standalone version (e.g., for visualization, reasoning services, support for specific data formats) and the recently-developed web version of Protégé supports the collaborative development of ontologies. Originally created to support the development of the Gene Ontology, OBO-Edit now serves as a general ontology editor [20, 21] .
Simpler than Protégé, OBO-Edit has been used to develop many of the ontologies from the Open Biomedical Ontologies (OBO) family. Rather than OWL, OBO-Edit uses a specific format, the OBO syntax, for representing ontologies. Both Protégé and OBO-Edit are open-source, platform independent software tools.
OBO Foundry and other harmonization efforts
Two major issues with biomedical ontologies are their proliferation and their lack of interoperability. There are several hundreds of ontologies available in the domain of life sciences, some of which overlap partially but do not systematically cross-reference equivalent entities in other ontologies. The existence of multiple representations for the same entity makes it difficult for ontology users to select the right ontology for a given purpose and requires the development of mappings between ontologies to ensure interoperability. Two recent initiatives have offered different solutions to address the issue of uncoordinated development of ontologies.
The OBO Foundry is an initiative of the Open Biomedical Ontologies (OBO) consortium, which provides guidelines and serves as coordinating authority for the prospective development of ontologies [22] . Starting with the Gene Ontology, the OBO Foundry has identified kinds of entities for which ontologies are needed and have selected candidate ontologies to cover a given subdomain, based on a number of criteria. Granularity and fundamental ontological distinctions form the basis for identifying subdomains. For example, independent continuants (entities) at the molecular level include proteins (covered by the protein ontology), while macroscopic anatomical structures are covered by the Foundational Model of Anatomy. In addition to syntax, versioning and documentation requirements, the OBO Foundry guidelines prescribe that OBO Foundry ontologies be limited in scope to a given subdomain and orthogonal. This means, for example, that an ontology of diseases referring to anatomical structures as the location of diseases (e.g., mitral valve regurgitation has location mitral valve) should cross-reference entities from the reference ontology for this domain (e.g., the Foundational Model of Anatomy for mitral valve), rather than redefine these entities. While well adapted to coordinating the prospective development of ontologies, this approach is extremely prescriptive and virtually excludes the many legacy ontologies used in the clinical domain, including SNOMED CT and the NCI Thesaurus.
The need for harmonization, i.e., making existing ontologies interoperable and avoiding duplication of development effort, has not escaped the developers of large clinical ontologies. SNOMED International, in charge of the development of SNOMED CT, is leading a similar harmonization effort in order to increase interoperability and coordinate the evolution of legacy ontologies and terminologies, including Logical Observation Identifiers Names and Codes (LOINC, for laboratory and clinical observations), the International Classification of Diseases (ICD), Orphanet (for rare diseases), the Global Medical Device Nomenclature Agency (for medical devices), and the International Classification for Nursing Practice (ICNP, for nursing diagnoses) [23] .
Ontologies of particular relevance to clinical research
Broadly speaking, clinical research ontologies can be classified into those that model the characteristics (or metadata) of the clinical research and those that model the data contents generated as a result of the research. [24] Research metadata ontologies center around characteristics like study design, operational protocol and methods of data analysis. They define the terminology and semantics necessary for formal representation of the research activity and aim to facilitate activities such as automated management of clinical trials and cross-study queries based on study design, intervention or outcome characteristics. Ontologies of data content focus on explicitly representing the information model of and data elements (e.g. clinical observations, laboratory test results) collected by the research, with the aim to achieve data standardization and semantic data interoperability. Important examples of the two types of ontology will be described in more detail.
Research metadata ontology
We did a survey of the public repositories of ontologies in the Open Biomedical Ontologies (OBO) library hosted by the National Center of Biomedical Ontology and the FAIRsharing.org website hosted by the University of Oxford. [25, 26] We used the keywords "clinical trial", "research" and "investigation" for searching.
We learned about the identified research metadata ontologies through their online information and literature search. Ontologies with little or no available information and evidence of ongoing use are not included here. We found three ontologies that are actively maintained and used: Ontology of Clinical Research (OCRe), Ontology for Biomedical Investigations (OBI) and Biomedical Research Integrated Domain Group model ontology (BRIDG).
Ontology of Clinical Research
The primary aim of OCRe is to support the annotation and indexing of human studies to enable cross-study comparison and synthesis. [27, 28] Developed as part of the Trial Bank Project, OCRe provides terms and relationships for characterizing the essential design and analysis elements of clinical studies.
Domain specific concepts are covered by reference to external vocabularies.
Workflow related characteristics (e.g. schedule of activities) and data structure specification (e.g. schema of data elements) are not within the scope of OCRe.
The three core modules of OCRe are: resulting in the creation of OBI, which aims to cover all biomedical investigations [32] .
Ontology for Biomedical Investigations
As OBI is an international, cross-domain initiative, the OBI Consortium draws upon a pool of experts from many fields, including even fields outside biology such as environmental science and robotics. The goal of OBI is to build an integrated ontology to support the description and annotation of biological and clinical investigations, regardless of the particular field of study. OBI also uses the BFO as its upper-level ontology and all OBI classes are a subclass of some BFO class. OBI covers all phases of the experimental process, and the entities or concepts involved, such as study designs, protocols, instrumentation, biological material, collected data and their analyses. OBI also represents roles and functions which can be used to characterize and relate these entities or concepts.
Specifically, OBI covers the following areas: 
Biomedical Research Integrated Domain Group (BRIDG) Model Ontology
The Biomedical Research Integrated Domain Group (BRIDG) Model is a collaborative effort engaging stakeholders from the Clinical Data Interchange Standards Consortium (CDISC, described in more detail in a later chapter), HL7
Regulated Clinical Research Information Management Technical Committee (RCRIM TC), National Cancer Institute (NCI) and US Food and Drug Administration (FDA). [33] [34] [35] The goal of the BRIDG Model is to produce a shared view of the dynamic and static semantics for the domain of protocol-driven research and its associated regulatory artifacts, defined as "the data, organization, resources, rules, and processes involved in the formal assessment of the utility, impact, or other pharmacological, physiological, or psychological effects of a drug, procedure, process, or device on a human, animal, or other subject or substance plus all associated regulatory artifacts required for or derived from this effort, including data specifically associated with post-marketing adverse event reporting". ontologies has also been demonstrated. [36] One of the future priorities of BRIDG is vocabulary binding. Historically, BRIDG is ontology and terminology agnostic and no formal binding is provided between vocabularies and classes and attributes within BRIDG. Recognizing the value of improving semantic interoperability, future work will bind BRIDG class attributes to one or more common terminologies from medicine and research.
The BRIDG model is available as an OWL ontology. It is also available as a UML representation (intended for domain experts and architects), and as an HL7 reference information model (RIM) representation in Visio files.
Data content ontology
While there are relatively few research metadata ontologies, there is a myriad of ontologies that cover research data contents. Unlike metadata ontologies, in this group the distinction between ontologies, vocabularies, classifications and code sets often gets blurred, and we shall refer to all of them as "terminologies". As clinical research is increasingly conducted based on EHR data (e.g., pragmatic trials), the separation between terminologies for clinical research and healthcare is also becoming less important. We have chosen several terminologies for more 
National Cancer Institute Thesaurus (NCIT)
NCIT is developed by the U.S. National Cancer Institute (NCI). It arose initially from the need for an institution-wide common terminology to facilitate interoperability and data sharing by the various components of NCI. [37] [38] [39] NCIT covers clinical and basic sciences as well as administrative areas. Even In the U.S., LOINC has been adopted by large reference laboratories, health information exchanges, health care organizations and insurance companies. LOINC is updated twice a year. Use of LOINC is free upon agreeing to the termsof-use in the license.
RxNorm
RxNorm is a standard nomenclature for medications developed by NLM. [46] RxNorm provides normalized names for clinical drugs and links its names to In the U.S., ICD-9-CM was used until 2015 and was replaced by ICD-10-CM.
Because of the requirement of ICD codes for reimbursement, they are ubiquitous in the EHR and insurance claims data. There is a four-fold increase in the number of codes from ICD-9-CM to ICD-10-CM, due to the more granular disease codes and capture of additional healthcare dimensions (e.g., episode of encounter, stage of pregnancy). [49] CMS provides forward and backward maps between ICD-9-CM and ICD-10-CM, which are called General Equivalence Maps (GEMs). These maps are useful for conversion of coded data between the two versions of ICD.
[50]
While ICD-9-CM covers both diagnosis and procedures, ICD-10-CM does not cover procedures. A brand-new procedure coding system called ICD-10-PCS was developed by CMS to replace the ICD-9-CM procedure codes for reporting of inpatient procedures. [51] ICD-10-PCS is a radical departure from ICD-9-CM and uses a multi-axial structure. Each ICD-10-PCS code has seven digits, each covering one aspect of a procedure such as body part, root operation, approach and device. As a result of the transition, there is a big jump in the number of procedure codes from about 4,000 to over 70,000.
Both ICD-10-CM and ICD-10-PCS are updated annually and are free for use without charge.
Current Procedural Terminology (CPT)
CPT is developed by the American Medical Association (AMA) to encode medical services and procedures. In the U.S., CPT is used to report physician services, many non-physician services, and surgical procedures performed in hospital outpatient departments and ambulatory surgery centers. The scope of [54] , other researchers have developed knowledge bases for cancer data (leveraging the NCI Thesaurus) [55] and in the domain of nicotine dependence (using an ontology developed specifically for the purpose of integrating publiclyavailable datasets) [56] . The Translational Medicine Knowledge Base, based on the Translational Ontology, is a more recent initiative developed for answering questions relating to clinical practice and pharmaceutical drug discovery [57] .
Ontology repositories
Because most biomedical terminologies and ontologies are developed by different groups and institutions independently of each other and made available to users in heterogeneous formats, interoperability among them is generally limited. In order to create some level of semantic interoperability among ontologies and facilitate their use, several repositories have been created. Such repositories provide access to integrated ontologies through powerful graphical and programming interfaces.
This section presents the two largest repositories: the Unified Medical Language System (UMLS) and the BioPortal.
Unified Medical Language System (UMLS)
The U.S. National Library of Medicine (NLM) started the UMLS project in 1986.
One of the main goals of UMLS is to aid the development of systems that help health professionals and researchers retrieve and integrate electronic biomedical information from a multitude of disparate sources. [58] [59] [60] [61] One major obstacle to cross-source information retrieval is that the same information is often expressed differently in different vocabularies used by the various systems and there is no universal biomedical vocabulary. Knowing that to dictate the use of a single vocabulary is not realistic, the UMLS circumvents this problem by creating links between the terms in different vocabularies. The UMLS is available free of charge. Users need to acquire a license because some of the UMLS contents are protected by additional license requirements. [62] Currently, there are over 20,000 UMLS licensees in more than 120 countries. The UMLS is released twice a year.
UMLS knowledge sources
The Metathesaurus of the UMLS is a conglomeration of a large number of terms that exist in biomedical vocabularies. All terms that refer to the same meaning The Semantic Network is another resource in the UMLS. The Semantic Network contains 127 semantic types and 54 kinds of relationship between the semantic types. The Semantic Network is primarily used for the categorization of UMLS concepts [9] . All UMLS concepts are assigned at least one semantic type. The semantic relationships represent the possible relationships between semantic types, which may or may not hold true at the concept level. A third resource in the UMLS is the SPECIALIST Lexicon and the lexical tools. The SPECIALIST Lexicon is a general English lexicon that includes over 500,000 lexical items.
Each lexicon entry records the syntactic, morphological and orthographic information that can be used to support activities such as natural language processing of biomedical text. The lexical tools are designed to address the high degree of variability in natural language words and terms. Normalization is one of the functions of the lexical tools that helps users to abstract away from variations involving word inflection, case and word order [63] .
UMLS tooling
The UMLS is distributed as a set of relational tables that can be loaded in a 
UMLS applications
The UMLS provides convenient one-stop access to diverse biomedical vocabularies, which are updated as frequently as resources allow. One important contribution of the UMLS is that all source vocabularies are converted to a common schema of representation, with the same file structure and object model. This makes it much easier to build common tools that deal with multiple vocabularies, without the need to grapple with the native format of each.
Moreover, this also enhances the understanding of the vocabularies as the common schema abstracts away from variations in naming conventions. For example, a term may be called 'preferred name', 'display name' or 'common name' in different vocabularies, but if they are determined to mean the same type of term functionally they are all referred to as 'preferred term' in the UMLS.
One common use of the UMLS is inter-terminology mapping. The UMLS concept structure enables easy identification of equivalent terms between any two source terminologies. In addition to mapping by synonymy, methods have been reported that create inter-terminology mapping by utilizing relationships and lexical resources available in the UMLS. [64] Natural language processing is another important use of the UMLS making use of its large collection of terms, the SPECIALIST Lexicon and the lexical tools. MetaMap is a publicly available tool developed by NLM which aims to identify biomedical concepts in free text. [65, 66] This is often the first step in data-mining and knowledge discovery. Other uses of the UMLS include terminology research, information indexing and retrieval, and terminology creation. [67] BioPortal BioBortal is developed by the National Center for Biomedical Ontology (NCBO), one of the National Centers for Biomedical Computing, created in 2004. The goal of NCBO is "to support biomedical researchers in their knowledge-intensive work, by providing online tools and a Web portal enabling them to access, review, and integrate disparate ontological resources in all aspects of biomedical investigation and clinical practice." BioPortal not only provides access to biomedical ontologies, but it also helps link ontologies to biomedical data [68] .
BioPortal ontologies
The current version of BioPortal integrates over 700 ontologies for biomedicine, biology and life sciences, and includes roughly 9 million concepts. A number of ontologies integrated in the UMLS are also present in BioPortal (e.g., Gene
Ontology, LOINC, NCIT, and SNOMED CT). However, BioPortal also provides access to the ontologies form the Open Biomedical Ontologies (OBO) family, an effort to create ontologies across the biomedical domain. In addition to the Gene Ontology, OBO includes ontologies for chemical entities (e.g., ChEBI), biomedical investigations (OBI), phenotypic qualities (PATO) and anatomical ontologies for several model organism, among many others. Some of these ontologies have received the "seal of approval" of the OBO Foundry (e.g., Gene
Ontology, ChEBI, OBI, and Protein Ontology). Finally, the developers of 
BioPortal tooling
BioPortal is a web-based application allowing users to search, browse, navigate, visualize and comment on the biomedical ontologies integrated in its repository.
For example, a search on "addison's disease" retrieves the corresponding entries in 51 ontologies (as of June 2018), including SNOMED CT, the Human Phenotype Ontology and DermLex. Visualization as tree or graph is offered for each ontology. The most original feature of BioPortal is to support the addition of marginal notes to various elements of an ontology, e.g., to propose new terms or suggest changes in relations. Such comments can be used as feedback by the developers of the ontologies and can contribute to the collaborative editing on ontologies. Users can also publish reviews of the ontologies. In addition to the graphical interface, BioPortal also offers an application programming interface (API) based on RESTful web services and is generally well integrated with Semantic Web technologies, as it provides URIs for each concept, which can be used as a reference in linked data applications.
BioPortal applications
Similar to the UMLS, BioPortal identifies equivalent concepts across ontologies in its repositories (e.g., between the term listeriosis in DermLex and in Medline Plus Health Topics). The BioPortal Annotator is a high-throughput named entity recognition system available both as an application and a web service. The Annotator identifies the names of biomedical concepts in text using fast string matching algorithms. While users can annotate arbitrary text, BioPortal also contains 40 million records from 50 textual resources, which have been preprocessed with the Annotator, including several gene expression data repositories, ClinicalTrials.gov and the Adverse Event Reporting System from the Food and Drug Administration (FDA). In practice, BioPortal provides an index to these resources, making it possible to use terms from its ontologies to search these resources. Finally, BioPortal also provides the Ontology Recommender, a tool that suggests the most relevant ontologies based on an excerpt from a biomedical text or a list of keywords.
Approaches to ontology alignment in ontology repositories
Apart from providing access to existing terminologies and ontologies, the UMLS and BioPortal also identify bridges between these artifacts, which will facilitate inter-ontology integration or alignment. For the UMLS, as each terminology is added or updated, every new term is comprehensively reviewed (by lexical matching followed by manual review) to see if they are synonymous with existing UMLS terms. If so, the incoming term is grouped under the same UMLS concept.
In the BioPortal, equivalence between different ontologies is discovered by a different approach. For selected ontologies, possible synonymy is identified through algorithmic matching alone (without human review). It has been shown that simple lexical matching works reasonably well in mapping between some biomedical ontologies in BioPortal, compared to more advanced algorithms [69] .
Users can also contribute equivalence maps between ontologies.
Ontology in action -Uses of ontologies in clinical research
Ontologies can be used to facilitate clinical research in multiple ways. In the following section, we shall highlight three areas for discussion: research workflow management, data integration and electronic phenotyping. However, these are not meant to be water-tight categories (e.g. the ontological modeling of the research design can facilitate workflow management, as well as data sharing and integration).
Research workflow management
In most clinical trials, knowledge about protocols, assays and specimen flow is stored and shared in textual documents and spreadsheets. The descriptors used are neither encoded nor standardized. Standalone computer applications are often used to automate specific portions of the research activity (e.g. trial authoring tools, operational plan builders, study site management software). These applications are largely independent and rarely communicate with each other.
Integration of these systems will result in more efficient workflow management, improve the quality of the data collected and simplify subsequent data analysis.
However, the lack of common terminology and semantics to describe the characteristics of a clinical trial impedes efforts of integration. Ontology-based integration of clinical trials management applications is an attractive approach. The advantage of an ontology-based approach in data capture is that the alignment of research semantics and data definition is achieved early in the research process, which facilitates greatly the downstream integration of data collected from different data sources. The early use of a common master ontology obviates the need of a post hoc mapping between different data and information models, which is time-consuming and error-prone. Similar examples can be found in the use of OBI and BRIDG. OBI is used to define a standard submission form for the Eukaryotic Pathogen Database project, which integrates genomic and functional genomics data for over 30 protozoan parasites.
[76] While the specific terms used for a specimen are mainly drawn from other ontologies (e.g., Gazetteer, PATO), OBI is used to provide categories for the terms used (e.g., sequence data) to facilitate the loading of the data onto a database and subsequent data mining. In the U.S., FDA has used the BRIDG as the conceptual model for the Janus Clinical Trials Repository (CTR) warehouse. To support drug marketing application, clinical trial sponsors need to submit subject-level data from trials in the CDISC format to the FDA for storage in the Janus CTR, which is used to support regulatory review and cross-study analysis. [77] 
Data integration
In the post-genomic era of research, the power and potential value of linking data from disparate sources is increasingly recognized. A rapidly developing branch of translational research exploits the automated discovery of association between clinical and genomics data. [78] Ontologies can play important roles at different strategic steps of data integration. [79] For many existing data sources, data sharing and integration only occurs as an after-thought. To align multiple data sources to support activities such as crossstudy querying or data-mining is no trivial task. The classical approach, warehousing, is to align the sources at the data level (i.e. to annotate or index all available data by a common ontology). When the source data are encoded in different vocabularies or coding systems, which is sadly a common scenario, data integration requires alignment or mapping between the vocabularies. Resources like the UMLS and BioPortal are very useful in such mapping activity.
Another approach to data integration is to align data sources at the metadata level, which allows effective cross database queries without actually pooling data in a common database or warehouse. The prerequisite to the effective query of a network of federated research data sources is a standard way to describe the characteristics of the individual sources. This is the role of a common research metadata ontology. OCRe (described above) is specifically created to annotate and align clinical trials according to their design and data analysis methodology. In a pilot study, OCRe is used to develop an end-to-end informatics infrastructure that enables data acquisition, logical curation and federated querying of human studies to answer questions such as "find all placebo-controlled trials in which a macrolide is used as an intervention". [28] Using similar approaches for data discovery and sharing, a brand-new platform called Vivli is created to promote the reuse of clinical research data. [80] Vivli is intended to act as a neutral broker between data contributor, data user and the wider data sharing community. It will provide an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
Another notable effort is BIRNLex which is created to annotate the Biomedical Informatics Research Network (BIRN) data sources. [56] The BIRN sources include image databases ranging from magnetic resonance imaging of human subjects, mouse models of human neurologic disease to electron microscopic imaging. BIRNLex not only covers terms in neuroanatomy, molecular species and cognitive processes, it also covers concepts such as experimental design, data types and data provenance. BIRN employs a mediator architecture to link multiple databases. The mediator integrates the various source databases by the use of a common ontology. The user query is parsed by the mediator, which issues database-specific queries to the relevant data sources each with their specific local schema. [81] The use of OBI in the Investigation, Study, Assay (ISA) Project is another example of ontology-based facilitation of data integration and sharing. The ISA Project supports managing and tracking biological experiment metadata to ensure its preservation, discoverability and re-use. [82] Concepts from OBI are used to annotate the experimental design and other characteristics, so that queries such as "retrieve all studies with balanced design" or "retrieve all studies where study groups have at least 3 samples" are possible. In a similar vein, the BRIDG model ontology is used in various projects to facilitate data exchange. One example is the SALUS (Security and interoperability in next generation Public Protection and
Disaster Relief (PPDR) communication infrastructures) Project of the European
Union. [83] BRIDG is used to provide semantics for the project's metadata repository to allow meaningful exchange of data between European electronic health records.
Other innovative approaches of using ontologies to achieve data integration have also been described. One study explored the possibility of tagging research data to support real-time meta-analysis. [84] Another described a prototype system for ontology-driven indexing of public data sets for translational research. [85] One particular form of data integration supported by ontologies is represented by what has become known as "Linked Data" in the Semantic Web community [86] .
The foundational idea behind linked data and the Semantic Web is that resources semantically annotated to ontologies can be interrelated when they refer to the same entities. In practice, datasets are represented as graphs in RDF, the Resource [92] and NIH Health Care Systems Collaboratory, [93] it has been demonstrated that EHR data can be used to develop research-grade disease phenotypes with sufficient accuracy to identify traits and diseases for biomedical research and clinical care.
Electronic phenotyping refers to activities and applications that use data captured in the delivery of healthcare (typically from EHRs and insurance claims) to identify individuals or populations (cohorts) with clinical characteristics, events or service patterns that are relevant to interventional, observational, prospective, and/or retrospective studies. [93] So far, the most tried-and-true approach to electronic phenotyping utilizes explicit, standardized queries -consisting of logical operators, data fields and list of codes often from standardized terminologies -that can be run against different data sources to identify comparable populations. Due to the heterogeneity across care settings, data models and patient populations, designing phenotype definitions is complex and often requires customization for different data sources. However, the validity of selected phenotype definitions and the comparability of patient populations across different health care settings has been reported. [94] [95] [96] [97] [98] Newer approaches in electronic phenotyping involving techniques such as machine learning have been studied with promising results. [99] [100] [101] [102] However, manually curated phenotype definitions are still the most commonly employed phenotyping method.
Most phenotype definitions to date use both structured and unstructured elements in the EHR. Structured elements usually include demographic information, billing codes, laboratory tests, vital signs and medications. Unstructured elements include clinical notes, family history, radiology reports, pathology reports and others.
Utilization of unstructured data elements usually require additional processing by natural language processing. So far, the most commonly used structured data are the billing codes -especially the ICD and CPT codes because of their ubiquity in the EHR. [103] With the increasing use of clinical terminologies such as SNOMED CT, LOINC and RxNorm as a result of the Meaningful Use and subsequent incentive programs, it is expected that the inclusion of these terminologies in phenotype definitions will increase. This should have a positive impact in the accuracy of phenotyping as clinical terminologies such as SNOMED CT have been shown to provide better coverage and more fine-grained representation of clinical information. [104] [105] [106] The use of standardized terminologies in the EHR will be a great boon towards making phenotype definitions fully computable and portable across data sources. [107] The use of robust terminologies can also make phenotype authoring more efficient. For example, the tools developed by the Informatics for Integrating Biology and the Bedside (i2b2) project leverage the intrinsic hierarchical structure of medical ontologies to allow the selection of all descendants under the same concept. [108] Before standardized terminologies become the norm, the diversity in content terminologies remains a challenge to electronic phenotyping. One approach to mitigate this problem is demonstrated by the OHDSI collaborative. The OHDSI vocabulary incorporates and maps terms from different terminologies to a core list of concepts.
Development of phenotype definitions is a time and resource intensive activity.
Often knowledge engineers, domain experts and researchers have to spend many hours to create and iteratively refine phenotype algorithms to achieve high sensitivity, specificity, positive and negative predictive values. It is highly likely that different research groups have the need to identify some common conditions such as type 2 diabetes mellitus. To ensure comparability of results and to avoid duplication of effort, it is important that phenotype definitions are validated and shared across institutional and organizational boundaries. One platform for the creation, validation and dissemination of phenotype definitions is the Phenotype Knowledgebase (PheKB) developed by the eMERGE Network. 
The Way Forward
Looking forward, it is encouraging that the value of ontologies in clinical research becomes more recognized. This is evidenced by the increase in the number of investigations making use of ontologies. At the same time, this is also accompanied by an increase in the number of ontologies, which in itself is a mixed blessing. Many researchers still tend to create their own ontologies to suit their specific use case. Re-use of existing ontologies is only a rarity. If left unchecked, this tendency has the potential of growing into the very problem that ontologies are created to solve -the multitude of ontologies will itself become the barrier to data interoperability and integration. Post hoc mapping and alignment of ontologies is often difficult (if not impossible) and an approximation at best (with inherent information loss). The solution is to coordinate the development and maximize the re-use of existing ontologies, which will significantly simplify things downstream.
To facilitate re-use of ontologies, resources like the UMLS and BioPortal are indispensable. They enable users to navigate the expanding sea of biomedical ontologies. In addition to listing and making these ontologies available, what is still lacking is a better characterization of these ontologies to help users decide whether they are suitable for the tasks at hand. In case there are multiple candidate ontologies, some indicators of quality (e.g. user base, ways in which they are used, user feedback and comments) will be very useful to help users decide on the best choice.
